Statistics

Total Visits

Views
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells 348

Total Visits Per Month

March 2026 April 2026 May 2026 June 2026 July 2026 August 2026 September 2026
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells 11 9 5 17 6 11 0

File Visits

Views
SCOPUS-2016-7-39-SID84993967394-a1.pdf 27

Top country views

Views
Russia 106

Top cities views

Views
Kazan 106

Search DSpace


Advanced Search

Browse

My Account

Statistics